← All stocks

Kura Oncology, Inc.

KURA Net buying

CIK 0001422143 #2514 in the set updated 22 Sep 2026

Bought (1 mo)

$1.24M

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$1.24M

+$1.24M against sales at will

By person

9 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

WILSON TROY EDWARD

President and CEO

$1.24M (1)

—

+$1.24M

914,650

1.03%

$11.33M

+226.5%

Bair Teresa Brophy

Chief Legal Officer

—

195,444

0.2197%

$2.42M

+168.5%

Leoni Mollie

Chief Medical Officer

—

182,345

0.2050%

$2.26M

+288.2%

Powl Brian T.

Chief Commercial Officer

—

169,269

0.1903%

$2.10M

+979.7%

FORD KATHLEEN

Chief Operating Officer

—

153,560

0.1726%

$1.90M

+22.5%

DOYLE THOMAS JAMES

SVP, Finance & Accounting

—

145,167

0.1632%

$1.80M

+175.7%

Burrows Francis

Chief Scientific Officer

—

32,424

0.0364%

$401.73K

+31.7%

Hasnain Faheem

Director

—

23,983

0.0270%

$297.15K

0.0%

Malley Thomas

Director

—

10,000

0.0112%

$123.90K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

WILSON TROY EDWARD

24 Aug 2026

President and CEO

Buy indirect

100,000

$12.39

$1.24M

Show all 1 transactions →

What was left out

Form 4 filings counted 3

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 3 Jan 2017